madeindet
2 weeks ago
From current filing: Apollo Biowellness represents the consolidation of five cutting-edge companies (one of which, Evolutionary Biologics, Inc., is already a subsidiary of Emergent Health Corp.) operating in the regenerative medicine industry, each of them complimentary to one another, all having unique offerings or capabilities. The result is a new, vertically integrated player in the regenerative wellness category. By focusing on the three largest segments of the regenerative medicine market, we are positioned to become a leader in the fields of musculoskeletal care, wound healing and dermatology.
Apollo will, when its planned acquisitions of Juventix and IPS are completed, operate the following businesses through its subsidiaries:
? Integrative Practice Solutions, LLC, or IPS, organized under the laws of the state of Florida, engaged in licensing of The Advanced Arthritis Relief Protocol™, sale and distribution of medical devices, clinical training, and medical integration services. IPS is established as a leader in the non-surgical outpatient treatment of Osteoarthritis. It has developed America’s largest osteoarthritis treatment network with 200 licensed clinics in 37 states. With its highly profitable, disruptive technology, IPS has carved out a niche for its services that leaves it open to very limited competition;
? MAXIMUS Men’s Health, or Maximus, organized under the laws of the state of Delaware, focusing on solutions for the modern health focused male. The combination of osteoarthritis treatments, with PRP, and new age biologic products has enabled us to create treatments for uniquely male problems such as sports injuries, hair loss, erectile dysfunction, and testosterone replacement under Maximus.
? Juventix Regenerative Medical, LLC, organized under the laws of the state of Florida, is our state-of-the-art Platelet-Rich Plasma, or PRP, offering. We have created a futuristic processing procedure that sets Juventix apart from all competition in the PRP world. This world-class PRP offering allows us to have a door opener which “starts the conversation” with doctors interested in regenerative medicine.
Our Acquired Companies are expected to have a large, seasoned base of established customers.
IPS features 221 current licensees of its patented Advanced Arthritis Relief Protocol™, in 35 states. Additionally, IPS sells unloading knee braces, medical supplies, and other consumables to a total of 468 past and current customers. Juventix supplies PRP blood processing kits, medical devices, and supplies to over 500 healthcare clinics in the Shared States, as well as limited distribution internally (primarily in the Middle East).
Juventix and our already owned subsidiary, Evolutionary Biologics sell biologic products to doctors in many fields. Both companies utilize 1099 sales representatives to call directly on the doctors who are potential customers.
madeindet
1 month ago
News: Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
ACCESSWIRE 7 hrs ago 0
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health Corp. (OTC Pink:EMGE) ("Emergent Health" or "EMGE") (The "Agreement"), with the closing having taken place on March 14, 2024. Resonate Blends, the parent company, will become known as Apollo Biowellness, Inc. ("Apollo Biowellness"). The company is now located at One Marine Plaza, Suite 305A, North Bergen, NJ 04047.
The Company (to be known as Apollo Biowellness) is a holding company focused on regenerative medicine sold primarily to doctor's offices and clinics, as well as the public. The Company now consists of the following subsidiaries: Evolutionary Biologics, Integrative Practice Solutions LLC and Juventix Regenerative Medical LLC, and soon-to-be-launched Maximus Mean's Health.
The Company, as Apollo Biowellness, is a synergistic ecosystem of companies disrupting the next generation of the $5.6 trillion Global Health & Wellness Market. The global regenerative medicine market is currently at $20.04 billion in 2021 and predicted to be worth around $125.54 billion by 2030. We offer a one-stop solution for regenerative medicine with superior proprietary products and processes focused on the $1.1 trillion Personal Care, Beauty and Anti-Aging markets, with products sold through professional offices and directly to consumers. Our offerings include skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis and more. We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.
Emergent Health Corp. will continue with the operations of Wholistic Brands, a majority-controlled subsidiary as a separate, but affiliated entity of the Parent Company, it is a brand that represents the best natural formulas made from plant-based ingredients, including shelf-stable plant-based exosomes. Wholistic is developing products in support of our suite of businesses while building a proprietary D2C and consumer business around clean wholistic health.
As part of the Agreement, Jim Morrison is the new Chairman of the Board of Directors and President/CEO of the Company. Morrison has stepped down as CEO/President of Emergent Health Corp. but will continue as Chairman of the Board of Directors of Emergent. The new management of Emergent will also be appointed and will report to the Board of the Company.
Jim Morrison is considered by many to be one of the leading personal care strategists in the world, as well as one of the top executives. Morrison was Chairman and President/CEO of Emergent Health Corp., a dynamic company in the wellness and regenerative biologics space. He has most recently been CEO of StarShop, which was the first celebrity-driven video shopping app, that was launched in partnership with SPRINT. His track record of leadership and accomplishment in the personal care products space has been unparalleled. Morrison was President of L'Oreal for over nine years. He was responsible for many acquisitions, including both Redken and Matrix, and top-line growth that averaged over 20% during his tenure. Prior to L'Oreal, Morrison was President and CEO of Graham Webb, one of the most successful startups in the hair care space. After leaving L'Oreal Morrison was CEO and owner of Sexy Hair Concepts for four years. In 2006, Business Week Magazine wrote, "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the industry is unmatched."
As part of the transaction, the Company is conveying the previous assets of Resonate Blends to prior management.
About the former parent company Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is the former parent company, and as part of the transaction all the Intellectual Property and assets associated with it are being conveyed and transferred back to the former founding executive of Resonate Blends.
Apollo Biowellness is the new parent company and has no connection with the previous business of Resonate Blends.
ABOUT EMERGENT HEALTH CORP./Apollo Biowellness, Inc. (OTCMarkets Pink EMGE)
Emergent Health curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Evolutionary Biologics is a new kind of biologics company founded for a clear purpose: bring cutting-edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's website.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Corporate Contact:
advertisement
MORE FROM THIS SECTION
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Missile targets ship off Yemen as rebels threaten wider campaign
Missile targets ship off Yemen as rebels threaten wider campaign
Across the US, batteries and green energies like wind and solar combine for major climate solution
Across the US, batteries and green energies like wind and solar combine for major climate solution
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191
Contact Information:
Jim Morrison
President/CEO
jmorrison@evolutionarybiologics.com
2032539191
Jim Zimbler
President, Emergent Health
jzimbler@emergenthealthcompany.com
6318061420
SOURCE: Resonate Blends, Inc.
View the original press release on newswire.com.
advertisement
RECOMMENDED FOR YOU
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Nissan, Honda explore partnership in electric vehicles
Nissan, Honda explore partnership in electric vehicles
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Copyright 2024 ACCESSWIRE. All Rights Reserved.
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
×
Please enjoy a free sample of
madeindet
7 months ago
Phoenix Motorcars Enters Electric School Bus Market with Order for 10 Zero Emission Buses from District of Columbia
Represents the Company’s initial order in the emerging and fast-growing electric school bus market
September 13, 2023 07:00 AM Eastern Daylight Time
ANAHEIM, Calif.--(BUSINESS WIRE)--Phoenix Motor Inc. (Nasdaq: PEV) (“Company” or “Phoenix”), a leader in manufacturing of all-electric, medium-duty vehicles, today announced a contract order for ten all electric, zero-emission Type-A school buses to be deployed from the Office of the State Superintendent of Education (OSSE). The contract was executed this summer and calls for the deployment of ten Phoenix school buses in the District of Columbia during 2024. The Phoenix Type-A School Buses will be built on Ford E-450 chassis powered by Phoenix’s 150-mile range battery electric drive system and a Pegasus Orion school bus body.
“The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District.”
Tweet this
“This is a vital first step to improving our carbon footprint and improving air quality in and around our schools and communities,” said State Superintendent Dr. Christina Grant. “The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District."
The Phoenix vehicles can be fully charged in less than two hours with a 100-kW Level III charger. The school buses, compared to their equivalent fossil fueled alternatives, can reduce atmospheric emissions by approximately 79 tons per vehicle annually, reduce maintenance costs by around 75% and lower fuel costs by approximately 80%.
“Phoenix is proud to be entering the electric school bus market. With this order, The District of Columbia is taking great steps to electrify its school bus fleet and cleaning the air quality near its students and in its communities,” Phoenix’s CEO Denton Peng said. “Our goal is to pave the way for the electrification of Type-A School Buses across America, and this project is a milestone for Phoenix Motorcars and our efforts to bring our leading electric drive system to every school district. We are committed to being the leader in zero emission Type-A School Buses and are excited to be partnered with Pegasus Specialty Vehicles.”
Phoenix has been the leader in medium-duty electrification for over a decade. With nearly 5 million all-electric miles driven on its zero-emission drive systems, Phoenix has extensive experience and expertise helping public and private fleets successfully deploy and adopt electric vehicles into their fleets, enhancing the air quality and providing clean, quiet and safe zero-emission transportation and mobility for their companies and communities.
“We couldn’t be happier to be able to partner with Phoenix Motorcars on this initial order for 10 Type-A school buses with Phoenix for the DC Schools,” said Pegasus President Brian Barrington. “We feel that utilizing our Orion body with the durable Phoenix EV drive system will be a great combination!”
About OSSE
The Office of the State Superintendent of Education (OSSE) is the state education agency for the District of Columbia charged with raising the quality of education for all DC residents. OSSE serves as the District’s liaison to the US Department of Education and works closely with the District’s traditional and public charter schools to achieve its key functions, including: Overseeing all federal education programs and related grants administered in the District of Columbia; Developing state-level standards aligned with school, college, and workforce readiness expectations; Ensuring access to high-quality child care and universal pre-kindergarten for eligible District families; Providing resources and support to assist the District’s most vulnerable student populations; Administering the annual statewide student academic achievement exam; Providing regional, door-to-door transportation to school for District children with special needs; Awarding higher education financial assistance to eligible District students at public and private colleges and universities in DC and across the country; Increasing health and physical education awareness as well as ensuring access to free meals year-round; and many other functions. Visit osse.dc.gov to learn more.
About Phoenix Motor Inc.
Phoenix Motor Inc., a pioneer in the electric vehicle (“EV”) industry, designs, builds, and integrates electric drive systems and light and medium duty EVs and sells electric forklifts and electric vehicle chargers for the commercial and residential markets. Phoenix operates two primary brands, “Phoenix Motorcars”, which is focused on commercial products including medium duty EVs (shuttle buses, school buses, municipal transit vehicles and delivery trucks, among others), electric vehicle chargers and electric forklifts, and “EdisonFuture”, which intends to offer light-duty EVs. Phoenix endeavors to be a leading designer, developer and manufacturer of electric vehicles and electric vehicle technologies. For more information, please visit: www.phoenixmotorcars.com.
About Pegasus Specialty Vehicles
Pegasus Specialty Vehicles is spearheaded by industry-proven leadership, experienced as reputable expert innovators in the school transportation and manufacturing industries. Its management team brings a culture of creativity, flexibility, effectiveness, efficiency and teamwork to producing competitively priced modern school and shuttle buses that address market needs that have been ignored by existing bus manufacturers. Located in West Central Ohio, Pegasus is positioned to service the entire U.S. and Canada from one location. The company provides buses for both the school and transit bus industries. Pegasus Bus leadership is well recognized by bus dealers, school bus contractors, school district transportation operators, and decision-makers who have expressed dissatisfaction with current products that do not provide the features these buyers need and want. Learn more at www.ridepegasus.net